In a precedential decision in Revvo Technologies, Inc. v. Cerebrum Sensor Technologies, Inc., the Director of the US Patent and Trademark Office (USPTO) John Squires vacated the Patent Trial and Appeal Board... Read more »
The US Patent and Trademark Office (USPTO) withdrew its April 19, 2024, notice of proposed rulemaking and proposed revised modifications to its existing rules governing institution of inter partes review (IPR) proceedings... Read more »
In Shockwave Medical, Inc. v. Cardiovascular Systems, Inc., the US Court of Appeals for the Federal Circuit affirmed a final written decision by the Patent Trial and Appeal Board (PTAB) that certain... Read more »
In Ancora Technologies, Inc. v. Roku, Inc., the US Court of Appeals for the Federal Circuit vacated the Patent and Trademark Appeal Board’s (PTAB) final written decisions in two inter partes review... Read more »
In Incyte Corp. v. Sun Pharmaceutical Industries, the US Court of Appeals for the Federal Circuit dismissed an inter partes review (IPR) petitioner’s appeal of its Patent Trial and Appeal Board (PTAB)... Read more »
The US Patent and Trademark Office (USPTO) rescinded prior guidance regarding discretionary denial procedure during post-grant patent challenges at the Patent Trial and Appeal Board (PTAB) involving parallel district court or International... Read more »
In Apple Inc. v. Gesture Technology Partners, the US Court of Appeals for the Federal Circuit held that the Patent Trial and Appeal Board (PTAB) could exercise jurisdiction over inter partes review... Read more »
The US Patent and Trademark Office (USPTO) issued a final rule updating existing rules governing who may practice before the Patent Trial and Appeal Board (PTAB) in proceedings under the Leahy-Smith America... Read more »
The US Patent and Trademark Office (USPTO) issued a final rule formalizing its Director Review process in Patent Trial and Appeal Board (PTAB) proceedings. Source link Read more »
The US Patent and Trademark Office (USPTO) extended through March 31, 2025 its motion to amend pilot program in Patent Trial and Appeal Board (PTAB) trial proceedings. Source link Read more »